SUBSCRIBE
SUBSCRIBE

IPO

Deals
Backed By a Genentech Alum, NGM Looks Like it Could be the Next Biotech IPO
March 3, 2015
 · 
3 min read
CALBIO15:
Deals
CALBIO15: Investors Will “Set Higher Bar” for Biotech IPOs in 2015 As Market Corrects, Says Panel
March 2, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Davis Biotech Arcadia Biosciences Files for $86 Million IPO
February 18, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area’s SteadyMed Files for $55 Million IPO
February 9, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
GlaxoSmithKline Brings Three Banks on Board to Advise on Potential IPO
February 4, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Boston’s Flex Pharma Upsizes IPO to $86 Million
January 29, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Cancer Biotech Kolltan Pharmaceuticals Inc. Withdraws $86 Million IPO
January 29, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Massachusetts’s Inotek Pharmaceuticals Corporation Sets Terms for $65 Million IPO
January 23, 2015
 · 
3 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Deals
Biotech IPOs Up 22% Since “Bubble” Year of 2000, Shows New Data
January 19, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Evolving GlaxoSmithKline Mulls Over More Unit IPOs
January 16, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Press Releases
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 6, 2026
 · 
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
 · 
3 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
 · 
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
 · 
4 min read
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
 · 
12 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
 · 
5 min read
Press Releases
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
 · 
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
 · 
4 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
 · 
3 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
 · 
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
 · 
4 min read
Press Releases
Lumexa Imaging Announces Launch of Initial Public Offering
December 2, 2025
 · 
2 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
November 19, 2025
 · 
1 min read
Press Releases
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
November 18, 2025
 · 
5 min read
Press Releases
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares
November 11, 2025
 · 
1 min read
Press Releases
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 10, 2025
 · 
2 min read
Load More